Cathepsin H indirectly regulates morphogenetic protein-4 (BMP-4) in various human cell lines
By: Matija Rojnik, Zala Jevnikar, Bojana Mirkovic, Damjan Janes, Nace Zidar, Danijel Kikelj and Janko Kos
Open Access
|Oct 2011References
- Turk V, Turk B, Turk D. Lysosomal cysteine proteases: facts and opportunities.2001;: 4629-33.
- Kirschke H. Cathepsin H. In: Barret AJ, Rawlings ND, Woessner JF.2nd edition. London: Elsevier Academic Press; 2004. p. 1089-92.
- Kirschke H, Barrett AJ, Rawlings ND.2nd edition. Oxford: Oxford University Press; 1998.
- Ritonja A, Popovic T, Kotnik M, Machleidt W, Turk V. Amino acid sequences of the human kidney cathepsins H and L.1988;: 341-5.
- Vasiljeva O, Dolinar M, Turk V, Turk B. Recombinant human cathepsin H lacking the mini chain is an endopeptidase.2003;: 13522-8.
- Nishimura Y, Kato K. Identification of latent procathepsin H in microsomal lumen: characterization of proteolytic processing and enzyme activation.1988;: 712-8.
- Kominami E, Tsukahara T, Hara K, Katunuma N. Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages.1988;: 225-8.
- Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer.2010;: 937-45.
- Wu SM, Huang YH, Yeh CT, Tsai MM, Liao CH, Cheng WL, et al. Cathepsin H regulated by the thyroid hormone receptors associate with tumor invasion in human hepatoma cells.2011;: 2057-69.
- Ciric E, Sersa G. Radiotherapy in combination with vascular-targeted therapies.2010;: 67-78.
- Gabrijelcic D, Svetic B, Spaic D, Skrk J, Budihna M, Dolenc I, et al. Cathepsins B, H and L in human breast carcinoma.1992;: 69-74.
- Schweiger A, Christensen IJ, Nielsen HJ, Sørensen S, Brünner N, Kos J. Serum cathepsin H as a potential prognostic marker in patients with colorectal cancer.2004;: 289-94.
- Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N, et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.1997;: 1815-22.
- Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, et al. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.1996;: 385-90.
- Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies.2008;: 69-81.
- Sivaparvathi M, Sawaya R, Gokaslan ZL, Chintala SK, Rao JS. Expression and the role of cathepsin H in human glioma progression and invasion.1996;: 121-6.
- Friedrich B, Jung K, Lein M, Türk I, Rudolph B, Hampel G, et al. Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissue.1999;: 138-44.
- Schweiger A, Staib A, Werle B, Krasovec M, Lah TT, Ebert W, et al. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.2000;: 782-8.
- Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Processing of pulmonary surfactant protein B by napsin and cathepsin H.2004;: 16178-84.
- Serveau-Avesque C, Martino MF, Hervé-Grépinet V, Hazouard E, Gauthier F, Diot E, et al. Active cathepsins B, H, K, L and S in human inflammatory bronchoalveolar lavage fluids.2006;: 15-22.
- Brasch F, Ten Brinke A, Johnen G, Ochs M, Kapp N, Müller KM, et al. Involvement of cathepsin H in the processing of the hydrophobic surfactantassociated protein C in type II pneumocytes.2002;: 659-70.
- D'Angelo ME, Bird PI, Peters C, Reinheckel T, Trapani JA, Sutton VR. Cathepsin H is an additional convertase of pro-granzyme B.2010;: 20514-9.
- Lü J, Qian J, Keppler D, Cardoso WV. Cathespin H is an Fgf10 target involved in Bmp4 degradation during lung branching morphogenesis.2007;: 22176-84.
- Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development.1996;: 1580-94.
- Deng H, Ravikumar TS, Yang WL. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.2009;: 220-31.
- Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.2009;: 520-9.
- Cui Y, Jean F, Thomas G, Christian JL. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development.1998;: 4735-43.
- Degnin C, Jean F, Thomas G, Christian JL. Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4.2004;: 5012-20.
- Goldman DC, Hackenmiller R, Nakayama T, Sopory S, Wong C, Kulessa H, et al. Mutation of an upstream cleavage site in the BMP4 prodomain leads to tissue-specific loss of activity.2006;: 1933-42.
- Schweiger A, Stabuc B, Popovíc T, Turk V, Kos J. Enzyme-linked immunosorbent assay for the detection of total cathepsin H in human tissue cytosols and sera.1997;: 165-72.
- Jevnikar Z, Obermajer N, Bogyo M, Kos J. The role of cathepsin X in the migration and invasiveness of T lymphocytes.2008;: 2652-61.
- Angliker H, Wikstrom P, Kirschke H, Shaw E. The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents.1989;: 63-8.
- Obermajer N, Svajger U, Bogyo M, Jeras M, Kos J. Maturation of dendritic cells depends on proteolytic cleavage by cathepsin X.2008;: 1306-15.
- Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins.2004;: 233-41.
- Kominami E, Tsukahara T, Bando Y, Katunuma N. Distribution of cathepsins B and H in rat tissues and peripheral blood cells.1985;: 87-93.
- del Re EC, Shuja S, Cai J, Murnane MJ. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas.2000;: 1317-26.
- Waghray A, Keppler D, Sloane BF, Schuger L, Chen YQ. Analysis of a truncated form of cathepsin H in human prostate tumor cells.2002;: 11533-8.
- Cui Y, Hackenmiller R, Berg L, Jean F, Nakayama T, Thomas G, et al. The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor.2001;: 2797-802.
- Takahashi T, Dehdarani AH, Tang J. Porcine spleen cathepsin H hydrolyzes oligopeptides solely by aminopeptidase activity.1988;: 10952-7.
- Ohkawara B, Iemura S, ten Dijke P, Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core.2002;: 205-9.
- Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W, et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells.2011;: 77-83.
- Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, et al. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice.2011;: 297-309.
- Goldman DC, Bailey AS, Pfaffle DL, Al Masri A, Christian JL, Fleming WH. BMP4 regulates the hematopoietic stem cell niche.2009;: 4393-401.
- Ardebili SY, Zajc I, Gole B, Campos B, Herold-Mende C, Drmota S, Lah TT. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids.2011;: 102-15.
Language: English
Page range: 259 - 266
Published on: Oct 8, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2011 Matija Rojnik, Zala Jevnikar, Bojana Mirkovic, Damjan Janes, Nace Zidar, Danijel Kikelj, Janko Kos, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.